Pharmacy to Dose: The Critical Care Podcast
ARDS Part II
Aug 11, 2023
Topics discussed include ESICM guidelines and definition of ARDS, phenotypes and respiratory support, corticosteroids, NMBA and VV ECMO, prone positioning in ARDS, absence of corticosteroids in guidelines, and personalized treatment strategies based on sub-phenotypes and biomarker profiles.
57:10
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- The diagnostic criteria for ARDS has been broadened to include patients on therapies like high-flow nasal oxygen, ensuring more inclusive diagnosis and proper treatment.
- The use of corticosteroids in ARDS remains uncertain and requires head-to-head studies to determine optimal dosing and duration in diverse populations.
Deep dives
Expanded Diagnostic Criteria for ARDS
One of the main takeaways from the 2023 ESICM guidelines for ARDS is the broadening of the diagnostic criteria to include patients on therapies such as high-flow nasal oxygen. This allows for a more inclusive diagnosis of ARDS and ensures that patients receiving these therapies are not excluded from proper recognition and treatment.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
